Quantum-Si Inc Ordinary Shares - Class A QSI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if QSI is a good fit for your portfolio.
News
-
Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024
-
Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing™ to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata
-
Quantum-Si Announces Presentations at ASMS and ESHG
-
Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors
-
Quantum-Si Reports First Quarter 2024 Financial Results
-
Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time
Trading Information
- Previous Close Price
- $1.15
- Day Range
- $1.08–1.23
- 52-Week Range
- $0.73–3.90
- Bid/Ask
- $1.09 / $1.19
- Market Cap
- $157.42 Mil
- Volume/Avg
- 535,733 / 808,997
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 121.28
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 165
- Website
- https://www.quantum-si.com
Comparables
Valuation
|
Metric
|
QSI
|
TIHE
|
VCYT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 191.42 |
Price/Book Value | 0.61 | — | 1.62 |
Price/Sales | 121.28 | — | 4.63 |
Price/Cash Flow | — | — | 32.22 |
Price/Earnings
QSI
TIHE
VCYT
Financial Strength
|
Metric
|
QSI
|
TIHE
|
VCYT
|
|---|---|---|---|
Quick Ratio | 29.56 | — | 4.41 |
Current Ratio | 30.65 | — | 5.00 |
Interest Coverage | — | — | −11,324.57 |
Quick Ratio
QSI
TIHE
VCYT
Profitability
|
Metric
|
QSI
|
TIHE
|
VCYT
|
|---|---|---|---|
Return on Assets (Normalized) | −27.45% | — | 8.19% |
Return on Equity (Normalized) | −29.81% | — | 8.76% |
Return on Invested Capital (Normalized) | −31.82% | — | 7.87% |
Return on Assets
QSI
TIHE
VCYT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Nnhzjmjb | Wvkfyyh | $183.1 Bil | |||
| Stryker Corp
SYK
| Wkphwwykb | Slng | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Spjqtktmx | Sncstvd | $109.2 Bil | |||
| Medtronic PLC
MDT
| Kvvxpcbyn | Hhrdly | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Hckcjfkcrz | Vlwrrwy | $37.6 Bil | |||
| DexCom Inc
DXCM
| Vzcrlvwsw | Ykcn | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Hryzscks | Mjtrmc | $24.3 Bil | |||
| Steris PLC
STE
| Zprwdjvf | Nkzxbyf | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Klgklqcmkn | Mkp | $22.8 Bil | |||
| Align Technology Inc
ALGN
| Ylrsmzv | Ntzdmw | $16.6 Bil |